Benjamin Haffemayer, Executive Director and Oncology TA Lead of Global Value and Access at Amgen, shared a post on LinkedIn:
“I’m excited to share that a few weeks ago I stepped into leading the Oncology Therapeutic Area for Global Value & Access at Amgen.
I’m looking forward to working with a talented and committed team of access leaders, united by a shared mission: helping patients affected by cancer gain access to meaningful innovation and care.
At a time of evolving policy landscapes around the world and increasing pressure on healthcare budgets, the role of access in product development and launch has never been more critical. The opportunity to help advance a dynamic and fast-progressing oncology portfolio for the benefit of patients feels especially meaningful.
Grateful for the opportunity and looking forward to what’s ahead.”